Diabete: dipeptyl peptidase-4 inhibitors and sulphonylureas, an association with potential risks

In the article published in the BMJ of may 2016, Francesco Salvo, researcher in the team “Pharmacoepidemiology and

logo_ISPED logo_SFR-santepublique-societe logo_CHU-Bordeaux logo_Institut-Bergonie logo_INRIA logo_ANRS logo_ARS logo_Charles-Perrens logo_IFSTTAR logo_HONcode